APA (7th ed.) Citation

Christopher J. Mowry, M., Cristina Alonso, P., Marta Iruarrizaga-Lejarreta, P., Pablo Ortiz, M., Josh Levitsky, M., & Mary Rinella, M. (2021). Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer.

Chicago Style (17th ed.) Citation

Christopher J. Mowry, MD, PhD Cristina Alonso, PhD Marta Iruarrizaga-Lejarreta, MD Pablo Ortiz, MD Josh Levitsky, and MD Mary Rinella. Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer, 2021.

MLA (8th ed.) Citation

Christopher J. Mowry, MD, et al. Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer, 2021.